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Received June 23, 2011; accepted September 20, 2011AbstractBackground: Pyogenic liver abscess (PLA) is seen as an endemic disease in population of Taiwan. The impact of advanced age on inpatients with
PLA remains unclear.
Methods: Data was collected and analyzed from claims of discharges by inpatients with PLA, using the National Health Insurance Research
Database of 2007.
Results: A total of 2319 subjects and 2651 related discharges were enrolled, including 939 subjects/1077 discharges 65 years and 1380
subjects/1574 discharges <65 years. Subjects 65 years had significantly higher ratios of females to males, nephropathy, biliary tract diseases,
liver cirrhosis and gastroenterological cancers than those <65 years. Hepatic/intra-hepatic duct cancers accounted for the most comorbid
gastroenterological cancers. Discharged of subjects 65 years had longer hospital stays, more in-hospital death/critical discharge, and a higher
ratio of acute low respiratory conditions (ALRC) and urological infections than those of subjects <65 years ( p< 0.05). The inpatient costs for
subjects 65 years were significantly higher than those for subjects age<65 years in blood products, hemodialysis and total hospitalization. Co-
morbidities, such as nephropathy, biliary tract diseases, liver cirrhosis, gastroenterological cancers, ALRC and urological infections were
predictive variables associated with age 65 years in patients with PLA, as were being female and in-hospital death/critical discharge.
Nephropathy and gastroenterological cancers were predictive variables associated with poor prognosis (in-hospital death/critical discharge) in
both PLA patients age < and 65 years ( p< 0.05). Diabetes mellitus featured predominantly, but had no impact on distribution and prognosis.
Conclusion: Advanced age (65 years) had an impact on the aforementioned characteristics and predictive variables in inpatients with PLA.
Physicians should pay attention and treat aged PLA patients with greater care, especially those cares with comorbid nephropathy or gastro-
enterological cancers.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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With the improvement of public health, pyogenic liver
abscess (PLA) has replaced amoebic infections as the major* Corresponding author. Dr. Shinn-Jang Hwang, Department of Family
Medicine, Taipei Veterans General Hospital, 201, Sec. 2, Shih-Pai Road,
Taipei 112, Taiwan, ROC.
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1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.10.010form of liver abscesses in developed countries. The character-
istics of PLA and its epidemiological distributions differ
geographically. For instance, the pathogenic distribution of
PLA is subtly different between Asia and Europe.1 The role of
co-morbid diabetes mellitus in PLA has interesting controver-
sies, as discovered by studies around the world.2e4 Present
evidence indicates a noticeable prevalence of PLA among the
population in eastern Asia. In Taiwan, PLA has seen as an
endemic disease.5 Local urban and rural hospital-based studies
have described some of its characteristics, such as a predominanthinese Medical Association. All rights reserved.
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pneumoniae infections, and some risk factors relating to
mortality.6e11
The geriatric society and the accelerated aging of health-
care populations are inevitable worldwide. In Taiwan, the
aging of society has been evident since 1993. The role of
advanced age in PLA should be a significant issue. However,
relevant information about the impact of advanced age on
patients with PLA still remains limited due to studies being
single hospitalebased.12e14 Using a nationwide database, the
aim of our study was to analyze and understand the afore-
mentioned issues.
2. Methods2.1. Data sourceRetrospective claim-based analyses were conducted. We
collected claim data of discharges by inpatients with PLA
from the National Health Insurance Research Database
(NHIRD) for 2007. The NHIRD was maintained by the
National Health Research Institute, Republic of China (Tai-
wan), which provided anonymous and encrypted claim data of
National Health Insurance for local research institutes.15
Under the authorization of NHIRD, we screened inpatients’
claim data (DD2007.DAT) and collected discharges with
major diagnosis of PLA by the International Classification of
Diseases, the Ninth Revision Clinical Modification (ICD-9-
CM), code 572.2.2. Study designTable 1
The demographic characteristics of subjects with pyogenic liver abscess as
major diagnosis in 2007 (n¼ 2319).
Parameters Subjects pa
Age 65 years
(n¼ 939)
Age <65 years
(n¼ 1380)
Mean age (years) 74.8 6.7 50.1 10.4
Mean frequency of
admission (times)
1.2 0.5 1.1 0.3 0.658
Gender (male/female) 514/425 936/444 <0.001
Major chronic comorbiditiesSubjects’ general data, co-morbidities, claims for charges
and predictive variables were analyzed. We classified subjects
and related discharges into 2 groups respectively by age 65
year. For results of hospitalization, we defined in-hospital
death and critical discharge (discharge with pre-dying condi-
tion for home death) as poor prognosis. The in-hospital costs
and details were calculated and converted to United States
dollars (USD). The co-morbidities were screened by relevant
ICD-9-CM codes. The chronic comorbidities included dia-
betes mellitus (250.x), nephropathy (580.x-589.x), biliary tract
diseases (574.x-576.x), liver cirrhosis (571.5), and gastroen-
terological cancers (150.x-159.x), and were analyzed by
counts of subjects. The acute comorbidities included acute low
respiratory conditions (ALRC) (466.x, 480.x-487.x) and
urological infections (590.x, 595.x, 597.x, 599.x, 601.x), and
were analyzed by counts of discharges. We did not enroll viral/
chronic hepatitis because of incomplete records of discharges
and ICD coding.Diabetes mellitus (yes/no) 355/584 553/827 0.279
Nephropathy (yes/no) 68/871 53/1327 <0.001
Biliary tract diseases 141/798 130/1250 <0.001
2.3. Statistical analyses(yes/no)
Liver cirrhosis (yes/no) 34/905 26/1354 0.011
Gastroenterological
cancers (yes/no)
87/852 62/1318 <0.001
a Independent t test and x2 test.Data in the text and tables are expressed as mean SD.
SPSS software (SPSS version 17.0, SPSS Inc., Chicago, IL,
USA) was used for statistical analysis. The independent t-test,
x2 test, trend x2 test and multiple logistic regression analysiswere used to assess statistical significance. The predictive
variables associated with advanced age (65 year) or poor
prognosis were presented as odds ratio (OR) and 95% confi-
dence interval (CI). A p value <0.05 was considered statisti-
cally significant (2-tailed test). Under the regulations of
research ethics, this study was conducted with the approval of
the National Health Research Institute, Republic of China (No.
99238).
3. Results
During 2007, 2319 patients with a major diagnosis of PLA
contributed to a total of 2651 discharges, including 939
subjects/1077 discharges age 65 years and 1380 subjects/
1574 discharges aged <65 years. The mean frequencies of
admissions did not differ significantly between the two groups
( p¼ 0.658 by independent t-test).
The subjects’ demographic characteristics are shown in
Table 1. Subjects 65 years included significantly more
females, and had more chronic comorbidities of nephropathy,
biliary tract diseases, liver cirrhosis, and gastroenterological
cancers than those <65 years. Diabetes mellitus featured
predominantly, but the distribution did not differ between the
two groups. Among comorbid gastroenterological cancers,
hepatic/intra-hepatic duct cancers (ICD-9-CM code 155;
n¼ 106) weremost numerous; colon cancers (code 153; n¼ 13)
and gallbladder/extra-hepatic duct cancers (code 156; n¼ 11)
ranked second and third, respectively.
Table 2 shows demographic characteristics of discharges
made by patients with PLA. Subjects discharged at age 65
years had longer hospital stays, more in-hospital death/critical
discharge, and a higher ratio of acute comorbidities such as
ALRC and urological infections than did those discharged at
<65 years. The majority of admissions were served by
department of internal medicine, followed by surgery.
The in-hospital costs and details are shown in Table 3.
Subjects discharged at age 65 years had significantly higher
Table 2
The demographic characteristics of discharges made by subjects with pyogenic
liver abscess as major diagnosis in 2007 (n¼ 2651).
Parameters Discharges by subjects pa
Age 65 years
(n¼ 1077)
Age <65 years
(n¼ 1574)
Mean hospital stay 17.8 11.4 16.5 10.1 0.003
Results (stable
discharge/in-hospital death
or critical discharge)
1040/37 1553/21 <0.001
Sections of admissions (%) 0.213
Family medicine 11 (1.0) 8 (0.5)
Internal medicine 920 (85.4) 1330 (84.5)
Surgery 131 (12.2) 215 (13.7)
Pediatrics 0 (0) 11 (0.7)
Neurology 8 (0.7) 6 (0.4)
Other sections 7 (0.6) 4 (0.3)
Major acute comorbidities
Acute low respiratory
conditions (yes/no)
73/1004 69/1505 0.008
Urological infections
(yes/no)
78/999 76/1498 0.011
a Independent t test, x2 test and trend x2 test.
Table 4
The significantly predictive variables associated with advanced age (65
years) in patients with pyogenic liver abscess (n¼ 2319).
Variables B value Odds ratio 95%CIb pa
Gastroenterological cancers 0.846 2.331 1.655-3.283 <0.001
In-hospital death/critical
discharge
0.748 2.112 1.209-3.691 0.009
Nephropathy 0.705 2.024 1.391-2.947 <0.001
Liver cirrhosis 0.671 1.956 1.166-3.283 0.011
Female 0.552 1.737 1.460-2.066 <0.001
Biliary tract diseases 0.509 1.663 1.284-2.155 <0.001
Acute low respiratory
conditions (ALRC)
0.477 1.612 1.139-2.279 0.007
Urological infections 0.396 1.485 1.064-2.075 0.020
a Multiple logistic regression analysis.
b CI¼ confidence interval.
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hospitalization than did those discharged at<65 years. The
difference in the daily costs of laboratory exams, radiological
exams and drug prescriptions differed insignificantly between
the two groups.
Under multiple logistic regression analyses, female gender
(OR¼ 1.737), in-hospital death/critical discharge (OR¼
2.112), nephropathy (OR¼ 2.024), biliary tract diseases
(OR¼ 1.663), liver cirrhosis (OR¼ 1.956), gastroenterolog-
ical cancers (OR¼ 2.331), ALRC (OR¼ 1.612) and urolog-
ical infections (OR¼ 1.485) were predictive variables
associated with advanced age (65 years) in patients with
PLA (all p< 0.05; Table 4). For prognosis of PLA, ALRC
served as a predictive variable for poor prognosis in PLA
patients <65 years (OR¼ 6.569). Nephropathy and gastroen-
terological cancers were both predictive variables associatedTable 3
The costs of discharges made by subjects with pyogenic liver abscess as major
diagnosis in 2007 (n¼ 2651).
Cost items (USDb) Discharges by subjects pa
Age 65 years
(n¼ 1077)
Age <65 years
(n¼ 1574)
Daily costs of laboratory
exams
24.2 26.1 23.6 28.2 0.547
Daily costs of radiological
exams
15.5 24.0 15.5 27.7 0.981
Daily costs of blood products 2.3 10.6 1.0 6.9 <0.001
Daily costs of hemodialysis 5.5 24.2 3.7 21.7 0.046
Daily costs of drug
prescriptions
46.9 37.6 47.8 52.0 0.634
Daily costs of hospitalization 180.7 133.9 169.1 169.7 0.062
Total costs of hospitalization 3082.1 3014.3 2594.7 2457.9 <0.001
a Independent t test.
b USD¼United States Dollars.with poor prognosis in all PLA patients (OR¼ 5.623 and
3.241, respectively, in age65 years; 7.038 and 4.689,
respectively, in age <65 years; all p< 0.05;Table 5).4. Discussion
In this study, the gender distribution of patients with PLA
reflected age-related factors. With advanced age, the ratio of
females in the population increased gradually due to having
a longer life expectancy than males. Furthermore, in-hospital
death/critical discharge accounted for a significantly higher
ratio of discharges of subjects 65 years than of those <65
years (3.4% versus 1.3%). This issue reflected the fact that
PLA still had underlying hazards in elderly patients and
needed aggressive treatment. Similar conclusions were also
found in reports from Southern Korea.12 Although depart-
ments of internal medicine and surgery provided >95% of
admission services for such illness in this study, other
departments had relevant knowledge in caring for patients
with PLA.
The in-hospital costs of PLA also reflected some aspects of
medical economics. The total costs of hospitalization were
higher in the subjects discharged by subjects 65 years due to
longer hospital stays than in those discharged subjects <65
years old. However, the daily costs of laboratory exams,Table 5
The significantly predictive variables associated with poor prognosis (in-
hospital death/critical discharge) in patients with pyogenic liver abscess
stratified by age 65 years.
Groups/Variables B value Odds
ratio
95%CIb pa
Age 65 years (n¼ 939)
Nephropathy 1.727 5.623 1.932-16.364 0.002
Gastroenterological cancers 1.176 3.241 1.283-8.188 0.013
Age <65 years (n¼ 1380)
Nephropathy 1.951 7.038 1.392-35.594 0.018
Gastroenterological cancers 1.545 4.689 1.270-17.306 0.020
Acute low respiratory conditions 1.882 6.569 1.722-25.059 0.006
a Multiple logistic regression analysis.
b CI¼ confidence interval.
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between the two groups. The longer hospital stay in geriatric
patients with PLA may imply complicated health status in this
group. Further prospective evaluations for standard treatments
of PLA are indicated.
The higher daily costs of blood products and hemodialysis
imply underlying hematological and renal problems in geri-
atric inpatients with PLA. Previous studies have reported
aforementioned problems as factors of poor prognosis, such as
anemia, coagulopathy and acute/chronic renal failure.2,5,8,16,17
Healthcare workers should keep this in mind while caring for
geriatric patients with PLA.
Among co-morbidities, the insignificant role of diabetes
mellitus (DM) was similar with that in previous local hospital-
based studies.2,5,6 However, some studies from Southern Korea
and Denmark reported opposite results.3,4,18 We consider that
PLA shows some unique characteristics in the population of
Taiwan. Further epidemiological comparisons among other
populations are indicated for PLA.
There have been several claim-based reports reflecting the
negative role of renal insufficiency for prognosis of PLA.5,16
Yang et al.19 reported that PLA combining with end-stage
renal disease had a high mortality rate. Okano et al.20 re-
ported that complicated PLA, such as co-morbid acute renal
failure, needed aggressive percutaneous drainage for effective
control. In this study, nephropathy contributed as a predictive
variable associated with age 65 years in PLA patients. The
results are similar to those of reports from Spain.13 We
conclude that underlying renal diseases should be considered
when assessing geriatric patients with PLA. This co-morbidity
also explains the aforementioned higher daily costs of
hemodialysis.
Biliary tract diseases have been viewed as a well-known co-
morbidity for PLA in previous studies.6,7,21,22 Our result also
proved this parameter and imposed its association with age
65 years in patients with PLA. What is also interesting is the
role that the gastroenterological cancers have played in PLA.
In the United States, a large claim-based analysis reported
cancer as a mortality-related factor for PLA.16 Another study
from Hong Kong also reported a similar role of hepato-biliary
cancers in PLA.23 Several case reports and series reflected
interesting roles of colon cancers and metastatic liver tumors,
with an initial presentation of PLA.24e27 There are case series
also reporting the relationships between PLA and hepato-
biliary malignancies, especially in those patients receiving
invasive therapies such as transarterial embolization.28e31 In
this study, the role of gastroenterological cancers in PLA and
the detailed classifications also showed similar characteristics.
Underlying malignancies in PLA should be kept in mind and
investigated further in highly-endemic areas.
Extra-hepatic complications, such as pulmonary or
urological infections, should be seen as problems associated
with age 65 years in patients with PLA, although the inci-
dence in their discharges was low (6.8 and 7.2%, respectively).
Liu et al. 32 reported that undiagnosed PLA (diagnosed after
admissions) often manifested symptoms of respiratory or
urinary tract infections in emergency rooms. Another series ofearly case also reflected similar infections in advanced age
patients with PLA.33 We concluded that PLA in advanced age
patients had more complications or co-morbidities than did
PLA in young adults due to impaired - condition commonly in
the elderly. Care providers should be aware of the possibility
of extra-hepatic infections in geriatric patients with PLA.
Liver cirrhosis was viewed as a risk factor of poor prog-
nosis in PLA patients by two epidemiological studies from the
United States and Denmark.16,34 Our results revealed
a predictive role of liver cirrhosis associated with geriatric
PLA patients, although liver cirrhosis itself did not achieve
statistic significance as a risk factor for poor prognosis. We
suggest that PLA patients with comorbid liver cirrhosis should
be treated carefully, especially those of advanced age.
Among predictive variables associated with advanced age
in patients with PLA, gastroenterological cancers, in-hospital
death/critical discharge and nephropathy all included high
ORs 2. The results reflected the underlying hazards and
health risks in caring for geriatric PLA patients. We suggest
that caring for PLA patients should be carefully evaluated,
along with other possible co-morbidities and prognosis,
especially for those patients with advanced ages. It should be
noted that both nephropathy and gastroenterological cancers
were predictive variables associated with poor prognosis in
PLA patients. Clinical physicians should pay more attentions
when PLA patients had aforementioned comorbidities.
The design of this study and the present parameters have
certain limitations. Screening with ICD-9-CM codes may not
entirely exclude artificial registry bias when establishing the
dataset. Incomplete records of discharges or ICD coding may
limit the investigation of some issues, such as viral/chronic
hepatitis. The timing relationships between PLA and some co-
morbidities, such as extra-hepatic infections and cancers, were
not clarified by the claim-based analyses. The details of
invasive procedures, serum markers, infecting microorgan-
isms, and pathological types of cancers, could not be clarified
due to limitations of the dataset itself. We utilized single-year
dataset due to limitations of authorization. Overall, this
nationwide claim-based analysis could illustrate the gross
characteristics and in-hospital costs for PLA inpatients, and
reveal the differences in those with advanced ages. Further
linkages of datasets could solve partial problems.
In conclusion, advanced age (65 years) had impact on the
aforementioned characteristics and predictive variables in
patients with PLA, such as a high ratio of females, long
hospital stays, poor prognosis, higher costs for blood products/
hemodialysis, and complicated co-morbidities. Physicians and
other medical staff should pay attention and treat carefully
aged PLA patients, especially those with comorbid nephrop-
athy or gastroenterological cancers.Acknowledgments
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